PharmiWeb.com - Global Pharma News & Resources

Biotech - Press Releases

Date Title Company
09-May-2024 EDWARDS LAUNCHES THE SAPIEN 3 ULTRA RESILIA VALVE WITH TECHNOLOGY TO ENHANCE DURABILITY Edwards Lifesciences
09-May-2024 PureTech Founded Entity Seaport Therapeutics Presents Data from Multiple SPT-300 Trials at Society of Biological Psychiatry (SOBP) Annual Meeting PureTech Health plc
09-May-2024 Nxera Pharma Operational Highlights and Consolidated Results for the First Quarter 2024 Nxera Pharma
09-May-2024 New Report Reveals The Extent of Life Science Sector's Perfect Storm Medicines Discovery Catapult (MDC)
09-May-2024 Teva and Medincell Announce Positive Phase 3 Efficacy Results from SOLARIS Trial Evaluating TEV-‘749 (olanzapine) as a Once-Monthly Subcutaneous Long-Acting Injectable in Adults with Schizophrenia MedinCell
09-May-2024 Gilead Sciences Appoints Peter Wickersham to Vice-President and General Manager in the UK and Ireland Gilead Sciences
09-May-2024 HUTCHMED Announces Appointment of Independent Non-executive Director and Member of Board Committee HUTCHMED
09-May-2024 DevPro Biopharma and Bespak Complete Early Feasibility Studies for New Groundbreaking Albuterol Inhaler DevPro Biopharma
08-May-2024 Dr. Tim Garnett, Former Chief Medical Officer of Eli Lilly, Joins Lindus Health's Advisory Board Lindus Health
07-May-2024 GILEAD AND KITE ONCOLOGY TO HIGHLIGHT BROAD AND DIVERSE ONCOLOGY PORTFOLIO AT ASCO 2024 Gilead Sciences, Inc
07-May-2024 Jo Goodman Joins Celerion as Vice President of Bioanalytical Services Celerion
07-May-2024 PureTech Founded Entity Seaport Therapeutics Adds Industry Veteran to Board of Directors and Makes Key Executive Appointments PureTech Health plc
07-May-2024 National approval for MOB-015 in all 13 countries Moberg Pharma AB
07-May-2024 Biocartis and Merck to Collaborate on Improving Patient Access to Personalized Medicine in Middle East and North Africa (MEA) Region Biocartis
07-May-2024 Atopia Therapeutics, Formerly HpVac, Announces Appointment of Dr. Gregoire Chevalier as CEO and Business Update Atopia Therapeutics
07-May-2024 Alfa Chemistry Provides Raw Material of THEIC for Multiple Industrial Applications Alfa Chemistry
03-May-2024 SynOx Therapeutics secures up to $35m debt financing with Hercules Capital to progress development and commercialisation of emactuzumab SynOx Therapeutics Limited
03-May-2024 NEW COMMERCIAL AGREEMENT WITH LARGE PHARMA ANGLE plc
03-May-2024 AAVantgarde announces its innovative clinical study design for its lead program in Usher 1B AAVantgarde Bio
02-May-2024 Lindus Health and University of Oxford Publish Study Citing Key Strategies to Foster Diversity in Clinical Trial Participation Site location, community reflective advertising, translation of study materials and social media outreach among the top methods Lindus Health